Browse Studies — Arctuva

Phase 3

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study With an Open-Label Extension Investigating Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism

The aim of the study is to evaluate the efficacy, safety, and tolerability of orally administered encaleret tablets in participants with chronic hypoparathyroi…

HypoparathyroidismChronic Hypoparathyroidism

Estimated

~$50 – $2,100

Actual pay is set by the research site.